ProfileGDS4718 / 234980_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 96% 88% 96% 95% 85% 82% 95% 96% 95% 95% 97% 88% 79% 73% 88% 92% 84% 89% 75% 96% 96% 94% 96% 92% 85% 94% 80% 96% 87% 94% 66% 96% 95% 76% 72% 91% 92% 95% 83% 95% 84% 79% 82% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]10.007694
GSM549102patient 115, normal, homogenized [OPG study]10.424396
GSM549104patient 119, normal, homogenized [OPG study]8.979788
GSM549108patient 138, normal, homogenized [OPG study]10.502296
GSM549119patient 077, normal, homogenized [OPG study]10.345695
GSM549133patient 032, cancer, homogenized [OPG study]8.6250785
GSM549139patient 042, cancer, homogenized [OPG study]8.0798482
GSM549099patient 107, normal, homogenized [OPG study]10.307495
GSM549109patient 139, normal, homogenized [OPG study]10.486496
GSM549110patient 046, normal, homogenized [OPG study]10.424195
GSM549114patient 063, normal, homogenized [OPG study]10.487895
GSM549122patient 082, normal, homogenized [OPG study]11.015897
GSM549134patient 033, cancer, homogenized [OPG study]8.8335288
GSM549136patient 036, cancer, homogenized [OPG study]7.8295679
GSM549140patient 044, cancer, homogenized [OPG study]7.1534873
GSM549111patient 047, normal, homogenized [OPG study]8.9199588
GSM549113patient 057, normal, homogenized [OPG study]9.6940492
GSM549132patient 031, cancer, homogenized [OPG study]8.2723984
GSM549137patient 038, cancer, homogenized [OPG study]9.0094489
GSM549142patient 047, cancer, homogenized [OPG study]7.2275675
GSM549100patient 110, normal, homogenized [OPG study]10.491396
GSM549107patient 135, normal, homogenized [OPG study]10.658796
GSM549115patient 068, normal, homogenized [OPG study]10.277494
GSM549116patient 072, normal, homogenized [OPG study]10.573596
GSM549120patient 078, normal, homogenized [OPG study]9.6938592
GSM549131patient 030, cancer, homogenized [OPG study]8.5485285
GSM549118patient 074, normal, homogenized [OPG study]10.087394
GSM549129patient 027, cancer, homogenized [OPG study]7.8835580
GSM549123patient 088, normal, homogenized [OPG study]10.639896
GSM549124patient 006, cancer, homogenized [OPG study]8.5415887
GSM549126patient 015, cancer, homogenized [OPG study]9.9464694
GSM549128patient 025, cancer, homogenized [OPG study]6.6130466
GSM549103patient 117, normal, homogenized [OPG study]10.47696
GSM549117patient 073, normal, homogenized [OPG study]10.483495
GSM549138patient 041, cancer, homogenized [OPG study]7.4401576
GSM549141patient 045, cancer, homogenized [OPG study]7.182972
GSM549130patient 028, cancer, homogenized [OPG study]9.1762991
GSM549101patient 111, normal, homogenized [OPG study]9.4956992
GSM549105patient 128, normal, homogenized [OPG study]10.297795
GSM549106patient 134, normal, homogenized [OPG study]8.3715783
GSM549112patient 048, normal, homogenized [OPG study]10.392895
GSM549125patient 011, cancer, homogenized [OPG study]8.2487284
GSM549127patient 024, cancer, homogenized [OPG study]7.8002679
GSM549135patient 035, cancer, homogenized [OPG study]8.2175982